New LaunchJun 25, 2026, 07:31 AM
OptimizeRx Launches AI-Powered Natural Language Audience Builder (NLAB)
AI Summary
OptimizeRx Corp. announced the launch of its patent-pending Natural Language Audience Builder (NLAB), an AI-powered tool designed for integration into demand-side platforms (DSPs) and agency media planning platforms. NLAB leverages real-world evidence and OptimizeRx's EHR network data to enable life sciences companies and marketers to create and manage custom healthcare provider (HCP) audiences more efficiently. This new technology, available for integration from August 2026, aims to enhance audience intelligence, expand the company's infrastructure role, and generate new recurring revenue streams.
Key Highlights
- OptimizeRx launched its patent-pending Natural Language Audience Builder (NLAB), an AI-powered tool.
- NLAB combines real-world evidence with proprietary EHR network data to create custom HCP audiences.
- It allows marketers to build NPI lists, view HCP profiles, and understand reach across media channels.
- The tool helps identify HCPs most likely to engage with EHR advertising.
- NLAB will be available for platform integration starting August 2026.
- The launch expands OptimizeRx's role as an infrastructure partner for the healthcare ecosystem.
- It is expected to help partners deliver differentiated value and create new recurring revenue streams.
Price Impact
More from OPRX